BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18617144)

  • 1. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis.
    Dowling P; Wormald R; Meleady P; Henry M; Curran A; Clynes M
    J Proteomics; 2008 Jul; 71(2):168-75. PubMed ID: 18617144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.
    Marimuthu A; Chavan S; Sathe G; Sahasrabuddhe NA; Srikanth SM; Renuse S; Ahmad S; Radhakrishnan A; Barbhuiya MA; Kumar RV; Harsha HC; Sidransky D; Califano J; Pandey A; Chatterjee A
    Biochim Biophys Acta; 2013 Nov; 1834(11):2308-16. PubMed ID: 23665456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
    Ohshiro K; Rosenthal DI; Koomen JM; Streckfus CF; Chambers M; Kobayashi R; El-Naggar AK
    Int J Oncol; 2007 Mar; 30(3):743-9. PubMed ID: 17273777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma.
    Jarai T; Maasz G; Burian A; Bona A; Jambor E; Gerlinger I; Mark L
    Pathol Oncol Res; 2012 Jul; 18(3):623-8. PubMed ID: 22350791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.
    Wu W; Tang X; Hu W; Lotan R; Hong WK; Mao L
    Clin Exp Metastasis; 2002; 19(4):319-26. PubMed ID: 12090472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesis.
    Schaaij-Visser TB; Brakenhoff RH; Jansen JW; O'Flaherty MC; Smeets SJ; Heck AJ; Slijper M
    J Proteomics; 2009 Jul; 72(5):803-14. PubMed ID: 19446051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.
    Baker H; Patel V; Molinolo AA; Shillitoe EJ; Ensley JF; Yoo GH; Meneses-García A; Myers JN; El-Naggar AK; Gutkind JS; Hancock WS
    Oral Oncol; 2005 Feb; 41(2):183-99. PubMed ID: 15695121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.
    Drake RR; Cazare LH; Semmes OJ; Wadsworth JT
    Expert Rev Mol Diagn; 2005 Jan; 5(1):93-100. PubMed ID: 15723595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein biomarker discovery for head and neck cancer.
    Schaaij-Visser TB; Brakenhoff RH; Leemans CR; Heck AJ; Slijper M
    J Proteomics; 2010 Sep; 73(10):1790-803. PubMed ID: 20139037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
    Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
    Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
    Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
    Zhao L; Liu Y; Sun X; Peng K; Ding Y
    J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
    Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
    Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.